Tags

Type your tag names separated by a space and hit enter

Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler.
J Occup Environ Med. 2008 Aug; 50(8):945-50.JO

Abstract

Increased international business travel to moderate or high endemic areas of hepatitis A and B may leave many business travelers at risk for infection if not vaccinated. Many international business travelers depart for hepatitis A and B endemic areas within 2 months of the decision to travel. Many of these travelers do not seek pretravel medical advice and are unaware of the risks and modes of acquiring hepatitis A and B. Monovalent vaccines and a combined hepatitis A and B vaccine are available and can be administered on an accelerated schedule. Because many areas endemic for hepatitis A are also endemic for hepatitis B, accelerated administration of the combined vaccine can offer protection for many international business travelers destined for areas endemic for both diseases and should be part of corporate travel immunization programs.

Authors+Show Affiliations

Division of Gastroenterology and Hepatology, New York Presbyterian Hospital-Cornell Medical Center, New York, NY, USA. bconnor@pol.netNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18695453

Citation

Connor, Bradley A., and Douglas J. Patron. "Use of an Accelerated Immunization Schedule for Combined Hepatitis a and B Protection in the Corporate Traveler." Journal of Occupational and Environmental Medicine, vol. 50, no. 8, 2008, pp. 945-50.
Connor BA, Patron DJ. Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler. J Occup Environ Med. 2008;50(8):945-50.
Connor, B. A., & Patron, D. J. (2008). Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler. Journal of Occupational and Environmental Medicine, 50(8), 945-50. https://doi.org/10.1097/JOM.0b013e3181808081
Connor BA, Patron DJ. Use of an Accelerated Immunization Schedule for Combined Hepatitis a and B Protection in the Corporate Traveler. J Occup Environ Med. 2008;50(8):945-50. PubMed PMID: 18695453.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler. AU - Connor,Bradley A, AU - Patron,Douglas J, PY - 2008/8/13/pubmed PY - 2009/2/12/medline PY - 2008/8/13/entrez SP - 945 EP - 50 JF - Journal of occupational and environmental medicine JO - J Occup Environ Med VL - 50 IS - 8 N2 - Increased international business travel to moderate or high endemic areas of hepatitis A and B may leave many business travelers at risk for infection if not vaccinated. Many international business travelers depart for hepatitis A and B endemic areas within 2 months of the decision to travel. Many of these travelers do not seek pretravel medical advice and are unaware of the risks and modes of acquiring hepatitis A and B. Monovalent vaccines and a combined hepatitis A and B vaccine are available and can be administered on an accelerated schedule. Because many areas endemic for hepatitis A are also endemic for hepatitis B, accelerated administration of the combined vaccine can offer protection for many international business travelers destined for areas endemic for both diseases and should be part of corporate travel immunization programs. SN - 1536-5948 UR - https://www.unboundmedicine.com/medline/citation/18695453/Use_of_an_accelerated_immunization_schedule_for_combined_hepatitis_A_and_B_protection_in_the_corporate_traveler_ L2 - https://doi.org/10.1097/JOM.0b013e3181808081 DB - PRIME DP - Unbound Medicine ER -